The All.Can Efficiency Metrics study has been featured in Cancerworld

An article summarizing the findings of the Efficiency Metrics study has been published on Cancerworld. On 17 June 2022, All.Can published its Efficiency Metrics study, a policy research which proposes a set of internationally applicable and real-world measures generated and collected from daily clinical practice….

Latest news

All.Can Efficiency Metrics study

On 17 June 2022, All.Can published its Efficiency Metrics study, a policy research which proposes a set of internationally applicable and real-world measures generated and collected from daily clinical practice.…

All.Can welcomes Lung Cancer Europe as new member

All.Can International is pleased to announce that Lung Cancer Europe (LuCE) has recently joined the multistakeholder organisation. Lung Cancer Europe is the voice of people living with lung cancer and…

All.Can joins the Access to Oncology Medicines (ATOM) Coalition

All.Can is glad to announce that we are part of the newly founded initiative Access to Oncology Medicines (ATOM) Coalition, established by UICC and its partners in a global effort…

Parties urged to back broad cancer care navigation pilot in Tasmania

Advocacy group All.Can Australia is calling on both sides of federal politics to commit to funding the first pilot site for a national approach to cancer care navigation in Tasmania.…

Annual report “All.Can at 5” now available

All.Can’s annual report “All.Can at 5” is now available for download. The annual report of All.Can presents the initiative’s achievements and milestones during its fifth year of existence, with two…

All.Can welcomes InoMed – the Centre for Innovation in Medicine as new member

All.Can International is pleased to announce that InoMed – the Centre for Innovation in Medicine has recently joined the multistakeholder organisation. InoMed is a European research and innovation non-governmental organisation,…

All.Can welcomes the Cancer Policy Institute Japan as new member

All.Can International is pleased to announce that the Cancer Policy Institute Japan (CPIJ) has recently joined the multistakeholder organisation. As part of its 20th anniversary, the Cancer Support Community Japan…

All.Can joins the ECO-ASCO Special Network on the Impact of the War in Ukraine on Cancer

All.Can has decided to support the ECO-ASCO Special Network on the Impact of the War in Ukraine on Cancer which allows the international cancer community to join forces.

All.Can feedback on the EU Cancer Screening Recommendation update

See All.Can submission on the European Commission website. All.Can has submitted a response to the European Commission’s call for evidence to update the EU Cancer Screening Recommendation. The new EU…